Henning Olbrich

555 total citations · 1 hit paper
23 papers, 235 citations indexed

About

Henning Olbrich is a scholar working on Pathology and Forensic Medicine, Rheumatology and Dermatology. According to data from OpenAlex, Henning Olbrich has authored 23 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in Rheumatology and 6 papers in Dermatology. Recurrent topics in Henning Olbrich's work include Urticaria and Related Conditions (7 papers), Autoimmune Bullous Skin Diseases (6 papers) and Dermatology and Skin Diseases (5 papers). Henning Olbrich is often cited by papers focused on Urticaria and Related Conditions (7 papers), Autoimmune Bullous Skin Diseases (6 papers) and Dermatology and Skin Diseases (5 papers). Henning Olbrich collaborates with scholars based in Germany, Israel and Sweden. Henning Olbrich's co-authors include Diamant Thaçi, Ralf J. Ludwig, Christian D. Sadik, Katharina Boch, Renata Stripecke, Henner Zirpel, Khalaf Kridin, Sebastian J. Theobald, Patrick Terheyden and Constança Figueiredo and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Frontiers in Immunology and British Journal of Dermatology.

In The Last Decade

Henning Olbrich

16 papers receiving 230 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX

2025 30 citations Ralf J. Ludwig, Matthew Anson et al. Frontiers in Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henning Olbrich Germany	8	84	70	69	57	54	23	235
Jennie T. Clarke United States	9	34 0.4×	43 0.6×	29 0.4×	70 1.2×	72 1.3×	26	205
J. Gottlieb France	9	90 1.1×	56 0.8×	49 0.7×	56 1.0×	63 1.2×	15	259
Julie Alejo United States	5	43 0.5×	39 0.6×	66 1.0×	44 0.8×	30 0.6×	5	188
Renee H. Grau United States	5	29 0.3×	55 0.8×	56 0.8×	150 2.6×	66 1.2×	7	258
Serena Fineschi Italy	7	31 0.4×	94 1.3×	44 0.6×	31 0.5×	43 0.8×	8	254
Liliane Khoryati France	8	46 0.5×	31 0.4×	165 2.4×	48 0.8×	16 0.3×	13	242
Shuni Ying China	5	28 0.3×	38 0.5×	157 2.3×	47 0.8×	118 2.2×	14	291
L. Gusdorf France	8	25 0.3×	60 0.9×	68 1.0×	123 2.2×	58 1.1×	20	273
Minnelly Luu United States	10	76 0.9×	23 0.3×	12 0.2×	28 0.5×	81 1.5×	26	233
Yuta Norimatsu Japan	9	20 0.2×	106 1.5×	84 1.2×	43 0.8×	63 1.2×	44	245

Countries citing papers authored by Henning Olbrich

Since Specialization

Citations

This map shows the geographic impact of Henning Olbrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henning Olbrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henning Olbrich more than expected).

Fields of papers citing papers by Henning Olbrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henning Olbrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henning Olbrich. The network helps show where Henning Olbrich may publish in the future.

Co-authorship network of co-authors of Henning Olbrich

This figure shows the co-authorship network connecting the top 25 collaborators of Henning Olbrich. A scholar is included among the top collaborators of Henning Olbrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henning Olbrich. Henning Olbrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Olbrich, Henning, et al.. (2026). COVID-19 Infection vs Vaccination and the Risk of New-onset Psoriasis. Acta Dermato Venereologica. 106. adv44217–adv44217.

Seebauer, Christian, et al.. (2025). HPV vaccination and malignancy risks beyond cervical cancer: A retrospective global cohort study. Pharmacological Research. 218. 107851–107851. 1 indexed citations

Recke, Andreas, Evelyn Gaffal, Jan Philipp Klein, et al.. (2025). Increased risk of psychiatric disease in patients with prurigo nodularis. British Journal of Dermatology. 193(2). 343–345.

Olbrich, Henning, Khalaf Kridin, Henner Zirpel, et al.. (2025). Glucagon-like peptide-1 receptor agonists and reduced mortality, cardiovascular and psychiatric risks in patients with psoriasis: a large-scale cohort study. British Journal of Dermatology. 194(1). 59–66. 1 indexed citations

Bieber, Katja, Henner Zirpel, Artem Vorobyev, et al.. (2025). Large-scale analysis highlights obesity as a risk factor for chronic, non-communicable inflammatory diseases. Frontiers in Endocrinology. 16. 1516433–1516433.

Olbrich, Henning, et al.. (2025). Increased risk of skin cancers in mucous membrane pemphigoid: a large-scale matched cohort study of 117 million US individuals. Frontiers in Medicine. 12. 1585167–1585167. 1 indexed citations

Olbrich, Henning, et al.. (2025). COVID-19 infection raises respiratory type 2 inflammatory disease risk, whereas vaccination is protective. Journal of Allergy and Clinical Immunology. 157(2). 517–524.

Ludwig, Ralf J., Matthew Anson, Henner Zirpel, et al.. (2025). A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX. Frontiers in Pharmacology. 16. 1516126–1516126. 30 indexed citations breakdown →

Olbrich, Henning, et al.. (2025). Reply. Journal of Allergy and Clinical Immunology. 157(1). 288–290.

10.

Zirpel, Henner, et al.. (2024). Atopic dermatitis is associated with an increased risk of cardiovascular diseases: a large-scale, propensity-score matched US-based retrospective study. Clinical and Experimental Dermatology. 49(11). 1405–1412. 4 indexed citations

11.

Olbrich, Henning, Khalaf Kridin, Gema Hernández, et al.. (2024). Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort study. EBioMedicine. 103. 105123–105123. 15 indexed citations

12.

Beek, Nina van, et al.. (2024). State-of-the-art diagnosis of autoimmune blistering diseases. Frontiers in Immunology. 15. 1363032–1363032. 12 indexed citations

13.

Kolkhir, Pavel, Katja Bieber, Tomasz Hawro, et al.. (2024). Mortality in adult patients with chronic spontaneous urticaria: A real-world cohort study. Journal of Allergy and Clinical Immunology. 155(4). 1290–1298. 3 indexed citations

14.

Kridin, Khalaf, Katja Bieber, Artem Vorobyev, et al.. (2024). Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasis. EBioMedicine. 111. 105485–105485. 3 indexed citations

15.

Olbrich, Henning, Christian D. Sadik, Ralf J. Ludwig, Diamant Thaçi, & Katharina Boch. (2023). Dupilumab in Inflammatory Skin Diseases: A Systematic Review. Biomolecules. 13(4). 634–634. 44 indexed citations

16.

Olbrich, Henning, Khalaf Kridin, Henner Zirpel, et al.. (2023). Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study. EBioMedicine. 93. 104639–104639. 22 indexed citations

17.

Olbrich, Henning, Christian D. Sadik, & Enno Schmidt. (2023). Autoimmune blistering diseases: promising agents in clinical trials. Expert Opinion on Investigational Drugs. 32(7). 615–623. 3 indexed citations

18.

Danisch, Simon, Reinhard Zeidler, Frank Klawonn, et al.. (2020). CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease. Molecular Therapy — Oncolytics. 18. 504–524. 50 indexed citations

19.

Olbrich, Henning, Sebastian J. Theobald, Andreas Schneider, et al.. (2020). Adult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus Infections. Human Gene Therapy. 31(7-8). 423–439. 26 indexed citations

20.

Olbrich, Henning, et al.. (2017). Reconstructing the immune system with lentiviral vectors. Virus Genes. 53(5). 723–732. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact